Affinity DataIC50: 10nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector
pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The
result...More data for this Ligand-Target Pair
Affinity DataIC50: 10nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector
pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The
result...More data for this Ligand-Target Pair
Affinity DataIC50: 13nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector
pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The
result...More data for this Ligand-Target Pair
Affinity DataIC50: 15nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector
pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The
result...More data for this Ligand-Target Pair
Affinity DataIC50: 15nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector
pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The
result...More data for this Ligand-Target Pair
Affinity DataIC50: 16nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector
pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The
result...More data for this Ligand-Target Pair
Affinity DataIC50: 17nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector
pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The
result...More data for this Ligand-Target Pair
Affinity DataIC50: 18nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector
pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The
result...More data for this Ligand-Target Pair
Affinity DataIC50: 18nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector
pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The
result...More data for this Ligand-Target Pair
Affinity DataIC50: 22nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector
pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The
result...More data for this Ligand-Target Pair
Affinity DataIC50: 23nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector
pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The
result...More data for this Ligand-Target Pair
Affinity DataIC50: 23nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector
pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The
result...More data for this Ligand-Target Pair
Affinity DataIC50: 24nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector
pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The
result...More data for this Ligand-Target Pair
Affinity DataIC50: 24nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector
pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The
result...More data for this Ligand-Target Pair
Affinity DataIC50: 26nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector
pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The
result...More data for this Ligand-Target Pair
Affinity DataIC50: 28nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector
pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The
result...More data for this Ligand-Target Pair
Affinity DataIC50: 30nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector
pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The
result...More data for this Ligand-Target Pair
Affinity DataIC50: 31nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector
pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The
result...More data for this Ligand-Target Pair
Affinity DataIC50: 34nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector
pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The
result...More data for this Ligand-Target Pair
Affinity DataIC50: 35nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector
pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The
result...More data for this Ligand-Target Pair
Affinity DataIC50: 41nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector
pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The
result...More data for this Ligand-Target Pair
Affinity DataIC50: 41nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector
pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The
result...More data for this Ligand-Target Pair
Affinity DataIC50: 42nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector
pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The
result...More data for this Ligand-Target Pair
Affinity DataIC50: 43nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector
pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The
result...More data for this Ligand-Target Pair
Affinity DataIC50: 46nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector
pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The
result...More data for this Ligand-Target Pair
Affinity DataIC50: 49nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector
pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The
result...More data for this Ligand-Target Pair
Affinity DataIC50: 50nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector
pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The
result...More data for this Ligand-Target Pair
Affinity DataIC50: 52nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector
pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The
result...More data for this Ligand-Target Pair
Affinity DataIC50: 52nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector
pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The
result...More data for this Ligand-Target Pair
Affinity DataIC50: 52nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector
pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The
result...More data for this Ligand-Target Pair
Affinity DataIC50: 53nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector
pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The
result...More data for this Ligand-Target Pair
Affinity DataIC50: 53nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector
pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The
result...More data for this Ligand-Target Pair
Affinity DataIC50: 53nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector
pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The
result...More data for this Ligand-Target Pair
Affinity DataIC50: 55nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector
pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The
result...More data for this Ligand-Target Pair
Affinity DataIC50: 55nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector
pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The
result...More data for this Ligand-Target Pair
Affinity DataIC50: 63nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector
pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The
result...More data for this Ligand-Target Pair
Affinity DataIC50: 65nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector
pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The
result...More data for this Ligand-Target Pair
Affinity DataIC50: 67nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector
pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The
result...More data for this Ligand-Target Pair
Affinity DataIC50: 68nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector
pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The
result...More data for this Ligand-Target Pair
Affinity DataIC50: 71nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector
pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The
result...More data for this Ligand-Target Pair
Affinity DataIC50: 72nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector
pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The
result...More data for this Ligand-Target Pair
Affinity DataIC50: 75nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector
pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The
result...More data for this Ligand-Target Pair
Affinity DataIC50: 76nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector
pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The
result...More data for this Ligand-Target Pair
Affinity DataIC50: 77nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector
pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The
result...More data for this Ligand-Target Pair
Affinity DataIC50: 77nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector
pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The
result...More data for this Ligand-Target Pair
Affinity DataIC50: 80nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector
pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The
result...More data for this Ligand-Target Pair
Affinity DataIC50: 80nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector
pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The
result...More data for this Ligand-Target Pair
Affinity DataIC50: 88nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector
pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The
result...More data for this Ligand-Target Pair
Affinity DataIC50: 91nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector
pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The
result...More data for this Ligand-Target Pair
Affinity DataIC50: 91nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector
pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The
result...More data for this Ligand-Target Pair